Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

Research and development (R&D) are essential elements of Eli Lilly’s operations, enabling the company to remain at the ...

Shares of Eli Lilly & Co. LLY slid 1.34% to $1,009.52 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.69% to 6,909.51 and ...

This was the stock's second consecutive day of losses.

Eli Lilly and Company LLY shares are up on Monday as the company benefits from positive market sentiment following Novo ...

Eli Lilly (LLY) achieved 54% year-over-year revenue growth to $17.6B in Q3. Tirzepatide is projected as the top-selling drug by 2030. Lilly raised its quarterly dividend 15% to $1.73 per share. The ...